Onset Therapeutics Announces Results Of BenzEFoam™ Skin Hydration Study

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced positive results from a skin moisturization study that compared the Company’s recently launched BenzEFoam™ (benzoyl peroxide 5.3%) Emollient Foam to a market leading combination gel containing clindamycin 1% – benzoyl peroxide 5%. BenzEFoam™ Emollient Foam is indicated for the topical treatment of mild to moderate acne vulgaris and is the first prescription foam formulation containing benzoyl peroxide as the active ingredient..

Link:
Onset Therapeutics Announces Results Of BenzEFoam™ Skin Hydration Study

Related posts:

1. BenzEFoamâ„¢ Emollient Foam More Effective In Reducing P. Acnes Bacteria Than Prescription Benzoyl Peroxide Cleanser Onset Therapeutics, a specialty pharmaceutical company focused on dermatology, announced...
2. New Study Assesses Skin Hydration And Epidermal Function Of 2.5% And 5% Benzoyl Peroxide-Clindamycin Combinations Las Vegas, NV – October 15, 2009 – Dermatologists agree...
3. Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study For Treatment Of Acne With The Microcyn(R) Technology Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that...
4. Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled… Conclusions: Topical nadifloxacin, a new fluoroquinolone is effective, tolerable, and...
5. Elorac, Inc. Announces Clinical Results Of Carbamide Peroxide Studies For The Treatment Of Acne Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message